Ara
Toplam kayıt 79, listelenen: 41-50
Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study
(Wiley, 2016)
What is known and objectiveAlthough inappropriate use of digoxin has been described in various populations, a real-world evaluation of patterns of digoxin prescription has not been well studied in patients with atrial ...
Right Ventricular Functions in Pulmonary Thromboembolism
(Karger, 2018)
Management of prosthetic valve thrombosis: what is the best dosage and administration route of thrombolytics
(Lippincott Williams & Wilkins, 2015)
Knowledge and attitudes towards hypertriglyceridaemia and associated residual risk amongst cardiologists in Turkey
(Edizioni Minerva Medica, 2021)
BACKGROUND: Hypertriglyceridemia (HTG) is an important component of residual risk. The knowledge regarding its treatment might not be at a desired level which might prevent patients from receiving the maximum benefit. We ...
Management Dilemma in Acute Prosthetic Valve Thrombosis: Surgery or Thrombolysis?
(Wiley-Blackwell, 2015)
Bridging anticoagulation in patients with mechanical heart valves
(Elsevier Ireland Ltd, 2017)
Rationale, design and methodology of the RAMSES Study: ReAl-life Multicenter Survey Evaluating Stroke Prevention Strategies
(Turkish Soc Cardiology, 2016)
Objective: Atrial fibrillation is the most common arrhythmia and is associated with a five-fold increased risk of thromboembolic events. Vitamin K antagonists (VKAs) have been the mainstay of oral anticoagulant prophylaxis ...
Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation
(Elsevier Ireland Ltd, 2016)
Letter to Editor
PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study)
(Sage Publications Inc, 2017)
Introduction: Inappropriate use of oral anticoagulants (OACs) have not been well investigatedand, however, may be frequent in real-world practice in patients with nonvalvular atrial fibrillation (NVAF). This study was ...
Comparison of the Stroke Prevention Strategies in the Aegean Region with the Other Regions of Turkey
(Excerpta Medica Inc-Elsevier Science Inc, 2017)
Epidemiological characteristics and treatment modalities
of non-valvular atrial fibrillation (NVAF) may differ according to geographical distribution in Turkey.